Clark Ian T
- SEC CIK
- 0001336504
In the past year, 4 open-market sale filings worth $13.9M and no purchases.
Current role at each company
- GH Guardant Health, Inc.Directoras of Aug 5, 2026
- OLMA Olema Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- CRVS Corvus Pharmaceuticals, Inc.Directoras of Jun 15, 2026
- BMRN Biomarin Pharmaceutical IncDirectoras of Jun 4, 2026
- KYTX Kyverna Therapeutics, Inc.Directoras of May 29, 2026
Show 3 more companies
- GDRX GoodRx Holdings, Inc.Directoras of Jul 9, 2025
- TECX Tectonic Therapeutic, Inc.Directoras of Jun 8, 2023
- AGIO Agios Pharmaceuticals, Inc.Directoras of May 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $13.9M
- 4 filings
- Net
- −$13.9M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Clark Ian T as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GH Guardant Health, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Clark Ian TDirector | SSale | −10.6K | $130.00 | −$1.37M | −100.0%0 after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Clark Ian TDirector | SSale | −1.08K | $130.00 | −$139.9K | −100.0%0 after | |
| Nov 14, 2024 (view filing) | Nov 12 | 2 days | Clark Ian TDirector | SSale | −8.32K | $29.45 | −$245.0K | −49.7%8.44K after | 2 lots |
| Jun 20, 2025 (view filing) | Jun 17 | 3 days | Clark Ian TDirector | SSale | −6.67K | $48.38 | −$322.8K | −40.4%9.85K after | 10b5-1 |
| Dec 8, 2025 (view filing) | Dec 5 | 3 days | Clark Ian TDirector | SSale | −28.6K | $107.19 | −$3.07M | −74.4%9.85K after | 3 lots |
| May 22, 2026 (view filing) | May 20 | 2 days | Clark Ian TDirector | SSale | −6.88K | $106.90 | −$735.0K | −69.8%2.98K after | |
| Aug 5, 2026 (view filing)5:05 PM ET | Aug 4 | 1 day | Clark Ian TDirector | SSale | −14.2K | $158.92 | −$2.25M | −82.7%2.98K after | 2 lots |
OLMA Olema Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 (view filing) | Dec 19 | 4 days | Clark Ian TDirector | SSale | −264.8K | $29.73 | −$7.87M | −100.0%0 after | 3 lots |